VERTEX PHARMACEUTICALS INC / MA (VRTX) Current Reports & Earnings Releases
Upcoming
- 2026-11-02 Earnings Release Estimated
| Filed | Form | Items | Filing |
|---|---|---|---|
| 2026-08-03 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-07-07 | 8-K | Material Agreement, Reg FD Disclosure, Other Events, Financial Statements & Exhibits | SEC |
| 2026-05-13 | 8-K | Officer / Director Changes, Shareholder Vote Results | SEC |
| 2026-05-04 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2026-04-29 | 8-K | Officer / Director Changes | SEC |
| 2026-03-31 | 8-K | Other Events | SEC |
| 2026-02-12 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-11-03 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-08-04 | 8-K | Results of Operations, Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2025-05-19 | 8-K | Other Events | SEC |
| 2025-05-14 | 8-K | Shareholder Vote Results | SEC |
| 2025-05-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2025-03-28 | 8-K | Other Events | SEC |
| 2025-02-10 | 8-K | Results of Operations, Officer / Director Changes, Financial Statements & Exhibits | SEC |
| 2024-12-20 | 8-K | Reg FD Disclosure | SEC |
| 2024-11-04 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-08-16 | 8-K | Material Agreement | SEC |
| 2024-08-01 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-06-27 | 8-K | Other Events | SEC |
| 2024-05-20 | 8-K | Other Events, Financial Statements & Exhibits | SEC |
| 2024-05-15 | 8-K | Shareholder Vote Results | SEC |
| 2024-05-06 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
| 2024-04-11 | 8-K | Material Agreement, Other Events, Financial Statements & Exhibits | SEC |
| 2024-02-05 | 8-K | Results of Operations, Financial Statements & Exhibits | SEC |
Sourced from SEC EDGAR 8-K/6-K filings. 8-K is the current-report form for US domestic issuers (Item 2.02 = earnings release); 6-K is the equivalent for foreign private issuers, including ADRs. Originals live on sec.gov.